Triple

T19157725
Position Surface form Disambiguated ID Type / Status
Subject ansuvimab E468967 entity
Predicate clinicalTrialContext P134656 FINISHED
Object evaluated during Ebola virus disease outbreaks in Africa LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: evaluated during Ebola virus disease outbreaks in Africa | Statement: [ansuvimab, clinicalTrialContext, evaluated during Ebola virus disease outbreaks in Africa]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: clinicalTrialContext
Context triple: [ansuvimab, clinicalTrialContext, evaluated during Ebola virus disease outbreaks in Africa]
  • A. coordinatesClinicalTrialsFor
    Indicates that one entity organizes, manages, or oversees the planning and execution of clinical trials on behalf of another entity.
  • B. hasClinicalTrialsIn
    Indicates that clinical trials related to an entity are being or have been conducted in a specified location or region.
  • C. clinicalTrialPhase
    Indicates the specific phase or stage of development a clinical trial is in within the overall clinical research process.
  • D. hasKeyClinicalTrial
    Indicates that an entity is associated with a primary or pivotal clinical trial that is especially important for its evaluation or approval.
  • E. trialOccurredIn
    Indicates that a particular trial took place within a specified location, venue, or jurisdiction.
  • F. None of above. chosen

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8dd084ff48190ac0f8c46ee722629 completed April 10, 2026, 11:20 a.m.
NER Named-entity recognition batch_69e5eeba91a081909c04d61d6117da06 completed April 20, 2026, 9:15 a.m.
PD Predicate disambiguation batch_69e4b9b83d6881908e6271c620f74100 completed April 19, 2026, 11:17 a.m.
PDg Predicate description generation batch_69e4bfe9ef7081908a74a57d1fc731ea completed April 19, 2026, 11:43 a.m.
Created at: April 10, 2026, 12:06 p.m.